scholarly article | Q13442814 |
P2093 | author name string | Shibata R | |
Adachi A | |||
Kawamura M | |||
Sakai H | |||
Ueda S | |||
Ono N | |||
Sakuragi S | |||
Ishimoto A | |||
Sakuragi J | |||
P2860 | cites work | Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 |
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 | ||
SV40-transformed simian cells support the replication of early SV40 mutants | Q28263905 | ||
Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
Integration of human immunodeficiency virus type 1 DNA in vitro | Q33608319 | ||
Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme | Q33859324 | ||
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells | Q34048204 | ||
Genetic recombination of human immunodeficiency virus | Q36782092 | ||
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release | Q36800610 | ||
Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants | Q36806278 | ||
Integration is not necessary for expression of human immunodeficiency virus type 1 protein products | Q36806287 | ||
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity | Q36825840 | ||
Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus | Q37546388 | ||
A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration | Q37573656 | ||
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus | Q37580568 | ||
Development of antiviral drugs for the treatment of AIDS: strategies and prospects | Q38668999 | ||
Functional comparison of transactivation by human retrovirus rev and rex genes | Q40105610 | ||
Mutational analysis of the human immunodeficiency virus vpr open reading frame. | Q40116997 | ||
Compatibility of rev gene activity in the four groups of primate lentiviruses | Q41663845 | ||
DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure | Q41747241 | ||
Requirement of the avian retrovirus pp32 DNA binding protein domain for replication | Q43946489 | ||
The terminal nucleotides of retrovirus DNA are required for integration but not virus production | Q45797460 | ||
Construction and analysis of deletion mutations in the pol gene of moloney murine leukemia virus: A new viral function required for productive infection | Q45804335 | ||
The HIV 'A' (sor) gene product is essential for virus infectivity | Q45847960 | ||
The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro | Q45851069 | ||
Generation and characterization of the human immunodeficiency virus type 1 mutants | Q45859881 | ||
DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells | Q64130379 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1169-1174 | |
P577 | publication date | 1993-03-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Integration is essential for efficient gene expression of human immunodeficiency virus type 1. | |
P478 | volume | 67 |
Q39878160 | 3'-end processing and kinetics of 5'-end joining during retroviral integration in vivo. |
Q78325092 | 3D-QSAR and molecular modeling of HIV-1 integrase inhibitors |
Q36984591 | A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector |
Q33604959 | AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung |
Q33853034 | Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. |
Q39996408 | Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus |
Q40307039 | Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction |
Q41504287 | Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains |
Q36408455 | Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials |
Q41841102 | Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus |
Q37457791 | Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions |
Q37386023 | Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. |
Q36538764 | Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations |
Q33782371 | Efficient gap repair catalyzed in vitro by an intrinsic DNA polymerase activity of human immunodeficiency virus type 1 integrase. |
Q33839450 | Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART. |
Q40162909 | Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species |
Q35861729 | Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection |
Q46612375 | Gag-Pol region determines the tropism of SIVagm for human cells |
Q34950830 | Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected] |
Q38290032 | Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain |
Q36629409 | Genetic analysis of the human immunodeficiency virus type 1 integrase protein. |
Q54633182 | HIV-1 integrase blocks infection of bacteria by single-stranded DNA and RNA bacteriophages. |
Q28367702 | HIV-1 integrase catalytic core: molecular dynamics and simulated fluorescence decays |
Q45767103 | High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA. |
Q39170765 | Histones Are Rapidly Loaded onto Unintegrated Retroviral DNAs Soon after Nuclear Entry |
Q34782531 | Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. |
Q40048140 | Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. |
Q40045880 | Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. |
Q30422793 | Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA. |
Q28368861 | Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism |
Q35829884 | Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells |
Q35890609 | Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro |
Q39606712 | Human immunodeficiency virus type 1 replication in the absence of integrase-mediated dna recombination: definition of permissive and nonpermissive T-cell lines |
Q37026630 | Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness |
Q34859768 | Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction |
Q39870518 | Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies |
Q36437723 | Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17 |
Q34143182 | Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives |
Q33929260 | Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31 |
Q28378926 | Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase |
Q36638299 | Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. |
Q35839212 | Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. |
Q33645102 | Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids |
Q33849497 | Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA. |
Q40939620 | Localization of HTLV-1 and HIV-1 proviral sequences in chromosomes of persistently infected cells. |
Q78043568 | Molecular electrostatic potentials as input for the alignment of HIV-1 integrase inhibitors in 3D QSAR |
Q59349655 | NP220 mediates silencing of unintegrated retroviral DNA |
Q39640904 | Patients on HAART often have an excess of unintegrated HIV DNA: Implications for monitoring reservoirs |
Q33654133 | Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development |
Q34412186 | Quantitative PCR used to assess HIV-1 integration and 2-LTR circle formation in human macrophages, peripheral blood lymphocytes and a CD4+ cell line |
Q37153500 | Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle |
Q36949688 | Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors |
Q28368842 | Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase |
Q34668065 | Retroviral Integrase Structure and DNA Recombination Mechanism |
Q37204656 | Retrovirus in salivary glands from patients with Sjögren's syndrome |
Q28345957 | Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase |
Q35882489 | Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. |
Q40883677 | Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents |
Q37399117 | Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors |
Q36078433 | The Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques. |
Q33717181 | The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integration |
Q37615893 | Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs |
Q35865664 | Unintegrated bovine leukemia virus DNA: association with viral expression and disease |
Q40584573 | Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants |
Q39963401 | Viral complementation allows HIV-1 replication without integration |